… these therapeutic targets. Finally we will briefly highlight some studies using multi-target drug
development for AD treatment. … Restoration of serotonergic function by selective serotonin …

SIRT2 as a potential new therapeutic target for Alzheimer’s disease … therapeutic target for
neurodegenerative diseases. This review summarizes and discusses the complex roles of …

… role of Aβ itself as a vasoactive factor and modulator of BBB integrity lends further support to
vascular Aβ accumulation as a potential therapeutic target … and serotonergic systems, have …

… a crucial role in regulating dopamine and serotonin levels in … dopaminergic and serotonin
from serotonergic neurons is … Benefits of using TAAR1 as a therapeutic target have already …

… Non-motor symptom treatments include selective serotonin reuptake inhibitors for mood and
… therapeutic target for various neurological disorders, including stroke, Alzheimer’s disease, …

… new drugs such as multi-target directed ligands (MTDLs), capable of interacting with multiple
therapeutic targets … cholinesterases) and the progression of the disease itself (Poliseno et al.…

Globodera pallida, a non-transgenic invertebrate as a new model for investigating Alzheimer’s
disease (and other proteinopathi Page 1 NEURAL REGENERATION RESEARCH|Vol 18|…

… (serotonin and dopamine, serotonin and histamine) which were sufficient to rescue cholinergic
function … a tool for screening drug targets for Alzheimer’s disease. Future Med 2:163-165. …

… ways by ASS234 may shed light to develop new therapeutic approaches. There are several
… -related diseases. These pathways or genes may act as therapeutic targets either increasing …

… “selective serotonin reuptake inhibitor”, Alzheimer’s disease”. We included studies done in
animal models with AD looking for the impact of SSRIs on the pathophysiological hallmarks of …